Profile
Göran Forsberg is the founder of Trainparts Sweden AB, founded in 2014.
Current jobs include Director at Mesenkia Therapeutics AB starting in 2025 and Independent Non-Executive Director at Disruptive Pharma AB starting in 2026.
Former jobs include Chief Executive Officer at Cantargia AB from 2014 to 2025, Non-Executive Director at Isogenica Ltd., Director at Active Security Trading AB, Director at Active Biotech Research AB, Director at Actinova AB, Independent Director at Guard Therapeutics International AB, Head-Business Development & Investor Relation at the University of Adelaide, Head-Business Development & Investor Relation at Kabigen AB, and Chief Business Officer & VP-Investor Relations at Active Biotech AB from 2011 to 2014.
Göran Forsberg active positions
| Companies | Position | Start |
|---|
Former positions of Göran Forsberg
| Companies | Position | End |
|---|---|---|
| CANTARGIA AB | Chief Executive Officer | 04/02/2025 |
| ACTIVE BIOTECH AB | Investor Relations Contact | 31/07/2014 |
Trainparts Sweden AB
Trainparts Sweden AB Metal FabricationProducer Manufacturing Engages in maintain, rebuild and remanufacture leaf springs, buffers and traction devices for railway vehicles | Founder | - |
University of Adelaide
University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Investor Relations Contact | - |
Kabigen AB | Investor Relations Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Active Biotech AB
Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
University of Adelaide
University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
Kabigen AB | |
Cantargia AB
Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Guard Therapeutics International AB
Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
Active Security Trading AB | |
Active Biotech Research AB
Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Actinova AB | |
Trainparts Sweden AB
Trainparts Sweden AB Metal FabricationProducer Manufacturing Engages in maintain, rebuild and remanufacture leaf springs, buffers and traction devices for railway vehicles | Producer Manufacturing |
- Stock Market
- Insiders
- Göran Forsberg
















